Nuvasive Inc NUVA

NAS: NUVA | ISIN: US6707041058 31/08/2023

39,75 USD (-2,24%)

(-2,24%) 31/08/2023

Grafiek Nuvasive Inc

Grafiek Nuvasive Inc

1 dag1d -2,24%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,00%
1 jaar1j -5,04%
5 jaar5j -34,38%

Nuvasive Inc in het nieuws

Toon enkel gratis nieuws

30 augustus 2023 · NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting · Persbericht

28 augustus 2023 · Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600 · Persbericht

2 augustus 2023 · NuVasive Announces Second Quarter 2023 Financial Results · Persbericht

24 juli 2023 · NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results · Persbericht

10 mei 2023 · NuVasive Announces First Quarter 2023 Financial Results · Persbericht

4 mei 2023 · NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results · Persbericht

27 april 2023 · NuVasive Shareholders Approve Merger Agreement with Globus Medical · Persbericht

17 april 2023 · Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical · Persbericht

14 april 2023 · Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical · Persbericht

11 april 2023 · NuVasive to Participate in Upcoming Global Spine Conferences · Persbericht

Profiel Nuvasive Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.nuvasive.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: J. Christopher Barry

Werknemers: 2.687

Aandelen Nuvasive Inc

Effecten: 52,45 miljoen

Winst per aandeel (12 maand): PLUS

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe